Kestra Medical Technologies, Ltd. - Common Stock (KMTS)

Revenue surged 66% in Q4 as prescriptions climbed 63% year over year.

Kestra Medical Technologies (NASDAQ:KMTS) reported a sharp increase in fourth-quarter revenue and issued fiscal 2027 guidance calling for continued growth, as executives said demand for the company’s ASSURE wearable cardioverter defibrillator system is being driven by new accounts, deeper penetratio

This cardiac device innovator saw a notable insider sale, as routine portfolio moves continue amid its push in digital health solutions.

This clinical-stage biotech develops bifunctional antibody therapies targeting solid tumors for oncology providers and institutions.

Alumis Inc. develops clinical-stage therapies targeting autoimmune and neuroinflammatory diseases using allosteric TYK2 inhibitors.

Kestra Medical Technologies develops advanced wearable cardiac devices and digital health solutions for cardiovascular care providers.

Kestra Medical Technologies, a specialist in wearable cardiac devices, reported a recent insider buy amid a year of share price declines.

Kestra Medical (KMTS) Q3 2026 Earnings Transcript

Kestra Medical (KMTS) Q2 2026 Earnings Transcript

Kestra Medical beats Q2 2026 revenue estimates but posts a wider-than-expected loss, triggering a sharp after-hours stock decline.

The US market regular session of Thursday is over, let's have a look at the top gainers and losers in the after hours session today.

Kestra Medical beats Q1 FY26 revenue and EPS estimates, sending its stock up nearly 9% in after-hours trading on strong operational performance.

ALISO VIEJO, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced the appointment of Raymond W. Cohen to its Board of Directors.

The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

KIRKLAND, Wash., July 15, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported financial results for the fourth quarter and fiscal year ended April 30, 2025.

Entrepreneur Of The Year celebrates ambitious entrepreneurs who are shaping the future

KIRKLAND, Wash., April 30, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, is scheduled to participate in the following upcoming investor conferences: